SYNA SYNAPTICS Inc
Semiconductors & Related Devices · Nasdaq · SEC CIK 817720 · Fiscal year ends 06/26
Financial factors as of 2026-09-26 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY8.1%
TTM net income YoY-977.0%
TTM EPS YoY-971.8%
Revenue 3-yr CAGR1.5%
Net income 3-yr CAGR—
Margins
Gross margin46.0%
Operating margin-4.7%
Net margin-40.7%
FCF margin5.4%
EBITDA margin-2.3%
Returns
ROE-42.1%
ROA-21.1%
ROIC (approx.)-2.8%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets55.3%
Debt / equity0.91x
Current ratio1.15x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.21x
Accruals ratio-25.6%
Payout ratio—
Capex / revenue3.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-06-27 | FY20252025-06-28 |
|---|---|---|
| Income statement | ||
| Revenue | $1.20B | $1.07B |
| Cost of revenue | $661.80M | $593.90M |
| Gross profit | $535.40M | $480.40M |
| R&D expense | $381.80M | $346.80M |
| SG&A expense | $198.30M | $180.30M |
| Operating income | -$67.10M | -$94.10M |
| Interest expense | $23.40M | $39.80M |
| Pretax income | -$79.40M | -$113.50M |
| Income tax | $411.40M | -$65.70M |
| Net income | -$490.80M | -$47.80M |
| EBITDA | -$36.30M | -$65.20M |
| EPS (basic) | -12.62 | -1.22 |
| EPS (diluted) | -12.62 | -1.22 |
| Weighted avg. shares (diluted) | 38.90M | 39.30M |
| Balance sheet | ||
| Cash & equivalents | $442.50M | $391.50M |
| Short-term investments | $0 | $61.00M |
| Receivables | $164.00M | $130.30M |
| Inventory | $156.40M | $139.50M |
| Current assets | $787.00M | $751.90M |
| PP&E, net | $86.90M | $72.10M |
| Goodwill | $872.30M | $872.30M |
| Intangibles | $187.80M | $262.20M |
| Total assets | $2.10B | $2.58B |
| Current liabilities | $701.30M | $270.90M |
| Short-term debt | $439.60M | $0 |
| Long-term debt | $397.70M | $834.80M |
| Total debt | $837.30M | $834.80M |
| Total liabilities | $1.17B | $1.19B |
| Shareholders' equity | $929.50M | $1.39B |
| Net debt | $394.80M | $443.30M |
| Shares outstanding | 39.06M | 38.64M |
| Cash flow statement | ||
| Operating cash flow | $149.40M | $142.00M |
| Capital expenditure | $48.00M | $25.80M |
| Free cash flow | $101.40M | $116.20M |
| Investing cash flow | $13.00M | -$297.90M |
| Financing cash flow | -$111.50M | -$331.40M |
| Depreciation & amortization | $30.80M | $28.90M |
| Stock-based compensation | $149.30M | $112.80M |
| Share buybacks | $92.70M | $128.30M |
Free plan shows the latest 2 periods; Pro shows all 18 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.